Skip NavigationSkip to Content

Global and targeted quantitative proteomics for biomarker discovery

  1. Author:
    Veenstra, T. D.
  2. Author Address

    SAIC Frederick Inc, Natl Canc Inst, Ft Detrick, MD 21702 USA.;Veenstra, TD, SAIC Frederick Inc, Natl Canc Inst, POB B, Ft Detrick, MD 21702 USA.;veenstra@ncifcrf.gov
    1. Year: 2007
    2. Date: Feb
  1. Journal: Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences
    1. 847
    2. 1
    3. Pages: 3-11
  2. Type of Article: Article
  3. ISSN: 1570-0232
  1. Abstract:

    The extraordinary developments made in proteomic technologies in the past decade have enabled investigators to consider designing studies to search for diagnostic and therapeutic biomarkers by scanning complex proteome samples using unbiased methods. The major technology driving these studies is mass spectrometry (MS). The basic premises of most biomarker discovery studies is to use the high data-gathering capabilities of MS to compare biological samples obtained from healthy and disease-afflicted patients and identify proteins that are differentially abundant between the two specimen. To meet the need to compare the abundance of proteins in different samples, a number of quantitative approaches have been developed. In this article, many of these will be described with an emphasis on their advantageous and disadvantageous for the discovery of clinically useful biomarkers. (c) 2006 Elsevier B.V. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.jchromb.2006.09.004
  2. WOS: 000244629200002

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel